Fidelity Investments
CRDF icon

Fidelity Investments’s Cardiff Oncology CRDF Stock Holding History

Fidelity Investments’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7K Sell
9,793
-31,103
-76% -$49.4K ﹤0.01% 4818
2026
Q1 		$66.3K Buy
40,896
+3,194
+8% +$6.56K ﹤0.01% 3986
2025
Q4 		$106K Buy
37,702
+5,502
+17% +$12.8K ﹤0.01% 3729
2025
Q3 		$66.3K Sell
32,200
-2,685
-8% -$7.42K ﹤0.01% 3841
2025
Q2 		$110K Sell
34,885
-1,272
-4% -$3.88K ﹤0.01% 3569
2025
Q1 		$114K Buy
36,157
+33,251
+1,144% +$131K ﹤0.01% 3501
2024
Q4 		$12.6K Buy
2,906
+1,381
+91% +$4.32K ﹤0.01% 4378
2024
Q3 		$4.07K Buy
1,525
+1,225
+408% +$2.89K ﹤0.01% 4662
2024
Q2 		$666 Buy
+300
New +$1.13K ﹤0.01% 4838
2023
Q4 		– Sell
-1,574
Closed -$2.19K – 5469
2023
Q3 		$2.19K Sell
1,574
-966
-38% -$1.63K ﹤0.01% 4522
2023
Q2 		$3.73K Sell
2,540
-4,805
-65% -$7.75K ﹤0.01% 4446
2023
Q1 		$12.1K Buy
7,345
+5,799
+375% +$9.96K ﹤0.01% 4054
2022
Q4 		$2.16K Buy
1,546
+105
+7% +$150 ﹤0.01% 4493
2022
Q3 		$2K Sell
1,441
-281
-16% -$676 ﹤0.01% 4531
2022
Q2 		$4K Sell
1,722
-19,976
-92% -$33.5K ﹤0.01% 4366
2022
Q1 		$54K Buy
+21,698
New +$76.7K ﹤0.01% 3655
2021
Q4 		– Sell
-6
Closed – – 4403
2021
Q3 		$0 Buy
+6
New +$38 ﹤0.01% 4424
2021
Q2 		– Sell
-149,780
Closed -$1.39M – 4321
2021
Q1 		$1.39M Sell
149,780
-698,620
-82% -$8.49M ﹤0.01% 2531
2020
Q4 		$15.3M Sell
848,400
-131,000
-13% -$2.3M ﹤0.01% 1818
2020
Q3 		$13.9M Buy
+979,400
New +$6.47M ﹤0.01% 1711
2019
Q3 		– Sell
-1
Closed – – 3820
2019
Q2 		$0 Buy
+1
New +$3 ﹤0.01% 3780
2018
Q4 		– Sell
-14
Closed – – 3586
2018
Q3 		$0 Buy
+14
New +$66 ﹤0.01% 3540

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Fidelity Investments's CRDF Position: Q2 2026 in Review

Fidelity Investments reduced its Cardiff Oncology (CRDF) stake by 76% in Q2 2026, selling an estimated $49.4K and leaving 9,793 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4818.

Fidelity Investments first reported a position in CRDF in Q3 2018 and has held it in 22 quarters since. The position peaked at $15.3M in Q4 2020. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Fidelity Investments held 9,793 shares of Cardiff Oncology worth $12.7K as of Q2 2026.
  • Fidelity Investments sold 31,103 Cardiff Oncology shares in Q2 2026, an estimated $49.4K.
  • Cardiff Oncology made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4818 holding.
  • Fidelity Investments first reported a position in Cardiff Oncology in Q3 2018 and has held it in 22 quarters since.
  • Fidelity Investments's Cardiff Oncology position peaked at $15.3M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.